Neuro-Oncological Perspectives on Cancer Stem Cell Biology in Glioblastoma: Implications for Resection, Recurrence, Targeted Therapy, and Other CNS Tumors
Cells · 27.02.2026 · 15 (5) · 413
DOI: 10.3390/cells15050413 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 27.02.2026. Verfasst von Karen Salmeron-Moreno und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, Emory University, Atlanta, GA 30329, USA. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Glioblastoma, Neoplasm Recurrence, Local, Central Nervous System Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 224 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer stem cells (CSCs) are increasingly recognized as central drivers of tumorigenesis, therapeutic resistance, and recurrence across diverse malignancies. This review synthesizes our current understanding of CSC biology across CNS tumors, with a focus on glioblastoma, where stem-like cells are sustained by specialized and overlapping tumor microenvironmental niches. Perivascular, hypoxic, invasive, immunosuppressive, and extracellular matrix-associated niches cooperatively enforce stemness, metabolic adaptability, immune evasion, and phenotypic plasticity, enabling CSC persistence despite maximal surgical resection and standard-of-care therapy. Notably, CSCs extend beyond radiographically defined tumor margins and populate peritumoral regions, providing a biological basis for near-universal recurrence. Advances in multiparametric imaging, stem cell-based ex vivo and in vivo models, and single-cell and spatial profiling have refined insight into CSC heterogeneity, niche dependence, and treatment resistance. Together, these findings reframe therapeutic strategies, highlighting the need for function-preserving maximal resection and multimodal therapies that target both CSC-intrinsic pathways and their supportive microenvironments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurological Surgery, Emory University, Atlanta, GA 30329, USA.
- Neurosurgery Department, Mayo Clinic, Jacksonville, FL 32224, USA.
ORCID-Profile: Karen Salmeron-Moreno, Chris Donghyun Kim, Josephine Buclez, Hithardhi Duggireddy, Hugo Guerrero-Cázares, Gustavo Pradilla
Zitieren
APA
Salmeron-Moreno, K., Papisetty, K., Kim, C. D., McCaffery, T., Kashlan, R., Theodore, J., Kim, J. M., Buclez, J., Duggireddy, H., Maldonado, J., Guerrero-Cázares, H., Pradilla, G., & Garzon-Muvdi, T. (2026). Neuro-Oncological Perspectives on Cancer Stem Cell Biology in Glioblastoma: Implications for Resection, Recurrence, Targeted Therapy, and Other CNS Tumors. Cells, 15(5), 413. https://doi.org/10.3390/cells15050413
Vancouver
Salmeron-Moreno K, Papisetty K, Kim CD, McCaffery T, Kashlan R, Theodore J, et al. Neuro-Oncological Perspectives on Cancer Stem Cell Biology in Glioblastoma: Implications for Resection, Recurrence, Targeted Therapy, and Other CNS Tumors. Cells. 2026;15(5):413. doi:10.3390/cells15050413
BibTeX
@article{SalmeronMoreno2026,
author = {Salmeron-Moreno, Karen and Papisetty, Karthik and Kim, Chris Donghyun and McCaffery, Thomas and Kashlan, Rommi and Theodore, John and Kim, Jennifer Minseo and Buclez, Josephine and Duggireddy, Hithardhi and Maldonado, Justin and Guerrero-Cázares, Hugo and Pradilla, Gustavo and Garzon-Muvdi, Tomas},
title = {Neuro-Oncological Perspectives on Cancer Stem Cell Biology in Glioblastoma: Implications for Resection, Recurrence, Targeted Therapy, and Other CNS Tumors},
journal = {Cells},
year = {2026},
volume = {15},
number = {5},
pages = {413},
doi = {10.3390/cells15050413}
}
EUVIMED